Sowmya Kaur, Brand Insights Contributor, Executive VP, Navitas Clinical Research and Head of Clinical – APAC, Navitas Life Sciences
Advertisement
Sowmya Kaur is the Executive Vice President and BU Head Clinical APAC/Russia at Navitas Life Sciences with a successful track record of building and leading Clinical Development engagements across Emerging Markets with successful delivery of portfolio of projects.
Articles by Sowmya Kaur, Brand Insights Contributor, Executive VP, Navitas Clinical Research and Head of Clinical – APAC, Navitas Life Sciences
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Clinical Trials in 2026: Platformization, AI Fluency, and the Redrawing of the Value Chain
2
FDA Issues Draft Guidance to Advance Bayesian Methods in Clinical Trials
3
Extending Trial Registries for an AI-Driven Era of Patient Discovery
4
ACT Brief: Moving Beyond AI Pilots, FDA Advances Bayesian Trials, and Sites Strained by Trial Design
5